Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Suven Life Sciences Limited (NSE: SUVEN), ISIN INE495B01038 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SUVEN last traded at ₹341.85 (+1.91%), with a 52-week range of ₹124.35 to ₹402.90 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 70.08%, FIIs 0.57%, DIIs 2.93%, mutual funds 0.01%.
EquiSense Score (ECS): 26/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.